| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 310,643 | 301,768 | 305,913 | 310,306 | | Cost of Revenue |
-
| (211,323) | 70,740 | 131,985 | | | Gross Profit | 310,643 | 513,091 | 235,173 | 178,321 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 224,991 | 417,166 | 129,782 | 73,748 | | Non Recurring | 20,730 |
-
|
-
|
-
| | Others | 4,873 | 10,168 | 12,130 | 13,360 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 60,049 | 85,757 | 93,261 | 91,213 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,926) | (6,391) | 38 | 1,710 | | Earnings Before Interest And Taxes | 58,123 | 78,111 | 90,844 | 90,903 | | Interest Expense |
-
| (3,193) | 1,379 | 1,814 | | Income Before Tax | 58,123 | 81,304 | 89,465 | 89,089 | | Income Tax Expense | 20,654 | 27,042 | 33,253 | 33,873 | | Minority Interest |
-
| (1,255) | (2,455) | (2,020) | | | | Net Income From Continuing Ops | 37,469 | 54,262 | 56,212 | 55,216 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 2,808 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 37,469 | 54,262 | 56,212 | 58,024 | | Preferred Stock And Other Adjustments | (2,334) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $35,135 | $54,262 | $56,212 | $58,024 |
|
0.45% Nasdaq 
0.20%
Income Statement
